Paper37726484
SARS-CoV-2 antibodies recognize 23 distinct epitopic sites on the receptor binding domain.
Jiang J and 6 others. Commun Biol, 2023. Cited by 24 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. SARS-CoV-2 antibodies recognize 23 distinct epitopic sites on the receptor binding domain. Papers, record 37726484. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37726484
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- SARS-CoV-2 antibodies recognize 23 distinct epitopic sites on the receptor binding domain.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Pandemics | Major topic |
| COVID-19 | Major topic |
| Humans | |
| SARS-CoV-2 | |
| Antibodies, Viral | |
| Spike Glycoprotein, Coronavirus | |
| Fluprednisolone |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Update of | 37,333,174 |
Source PubMed
References72
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35,772,405 | Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum. | Cell | 2022 | https://conductscience.org/library/papers/35772405 | PubMed |
| 2 | 35,438,546 | An antibody class with a common CDRH3 motif broadly neutralizes sarbecoviruses. | Sci Transl Med | 2022 | https://conductscience.org/library/papers/35438546 | PubMed |
| 3 | 34,537,245 | Structures of synthetic nanobody-SARS-CoV-2 receptor-binding domain complexes reveal distinct sites of interaction. | J Biol Chem | 2021 | https://conductscience.org/library/papers/34537245 | PubMed |
| 4 | 33,169,668 | Biochemical patterns of antibody polyreactivity revealed through a bioinformatics-based analysis of CDR loops. | Elife | 2020 | https://conductscience.org/library/papers/33169668 | PubMed |
| 5 | 33,756,110 | The antigenic anatomy of SARS-CoV-2 receptor binding domain. | Cell | 2021 | https://conductscience.org/library/papers/33756110 | PubMed |
| 6 | 32,225,175 | Structural basis of receptor recognition by SARS-CoV-2. | Nature | 2020 | https://conductscience.org/library/papers/32225175 | PubMed |
| 7 | 34,554,826 | Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study. | Science | 2021 | https://conductscience.org/library/papers/34554826 | PubMed |
| 8 | 26,193,119 | Contacts-based prediction of binding affinity in protein-protein complexes. | Elife | 2015 | https://conductscience.org/library/papers/26193119 | PubMed |
| 9 | 34,244,522 | Potent and protective IGHV3-53/3-66 public antibodies and their shared escape mutant on the spike of SARS-CoV-2. | Nat Commun | 2021 | https://conductscience.org/library/papers/34244522 | PubMed |
| 10 | 5,551,392 | The interpretation of protein structures: estimation of static accessibility. | J Mol Biol | 1971 | https://conductscience.org/library/papers/5551392 | PubMed |
| 11 | 2,687,698 | Conformations of immunoglobulin hypervariable regions. | Nature | 1989 | https://conductscience.org/library/papers/2687698 | PubMed |
| 12 | 32,661,058 | Structural basis of a shared antibody response to SARS-CoV-2. | Science | 2020 | https://conductscience.org/library/papers/32661058 | PubMed |
| 13 | 36,085,335 | Arsenal of nanobodies shows broad-spectrum neutralization against SARS-CoV-2 variants of concern in vitro and in vivo in hamster models. | Commun Biol | 2022 | https://conductscience.org/library/papers/36085335 | PubMed |
| 14 | 37,261,904 | Modeling of ACE2 and antibodies bound to SARS-CoV-2 provides insights into infectivity and immune evasion. | JCI Insight | 2023 | https://conductscience.org/library/papers/37261904 | PubMed |
| 15 | 2,454,644 | Three-dimensional structure of antibodies. | Annu Rev Immunol | 1988 | https://conductscience.org/library/papers/2454644 | PubMed |
| 16 | 28,588,190 | An optimal distance cutoff for contact-based Protein Structure Networks using side-chain centers of mass. | Sci Rep | 2017 | https://conductscience.org/library/papers/28588190 | PubMed |
| 17 | 36,535,326 | Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution. | Nature | 2023 | https://conductscience.org/library/papers/36535326 | PubMed |
| 18 | 34,155,209 | Sequence signatures of two public antibody clonotypes that bind SARS-CoV-2 receptor binding domain. | Nat Commun | 2021 | https://conductscience.org/library/papers/34155209 | PubMed |
| 19 | 37,023,193 | Germline-encoded amino acid-binding motifs drive immunodominant public antibody responses. | Science | 2023 | https://conductscience.org/library/papers/37023193 | PubMed |
| 20 | 35,412,617 | Search and sequence analysis tools services from EMBL-EBI in 2022. | Nucleic Acids Res | 2022 | https://conductscience.org/library/papers/35412617 | PubMed |
Cited by21
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,943,361 | Computational Assessment of CKP-25 Binding at Receptor-Recognition Interfaces Across Diverse Human Coronaviruses. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42943361 | PubMed |
| 42,538,972 | Localized Rigidification and Allosteric Modulation Mechanisms of SARS-CoV-2 Spike Neutralization by Class 3 and Class 4 Antibodies at Atomic Resolution: An Integrated Computational Study of Binding, Dynamics, and Allostery. | bioRxiv | 2026 | https://conductscience.org/library/papers/42538972 | PubMed |
| 42,123,600 | Mechanisms of Binding and Immune Escape Resistance for Broadly Neutralizing Antibodies Targeting Distinct Conserved SARS-CoV-2 Spike Epitopes: A Hierarchical Approach Integrating Mutational Profiling and Energy Landscape Analysis. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42123600 | PubMed |
| 41,959,354 | Frustration Landscapes of Broadly Neutralizing SARS-CoV-2 Spike Antibodies Targeting Conserved Epitopes Reveal Energetic Logic of Escape-Proof and Escape-Prone Mechanisms. | bioRxiv | 2026 | https://conductscience.org/library/papers/41959354 | PubMed |
| 41,629,525 | Structural mechanism of anti-MHC-I antibody blocking of inhibitory NK cell receptors in tumor immunity. | Commun Biol | 2026 | https://conductscience.org/library/papers/41629525 | PubMed |
| 41,542,366 | CoV-UniBind: a unified antibody binding database for SARS-CoV-2. | Bioinform Adv | 2026 | https://conductscience.org/library/papers/41542366 | PubMed |
| 41,333,432 | Structural mechanism of anti-MHC-I antibody blocking of inhibitory NK cell receptors in tumor immunity. | Res Sq | 2025 | https://conductscience.org/library/papers/41333432 | PubMed |
| 41,309,056 | Isolation of neutralizing antibodies against SARS-CoV-2 through an epitope-guided negative screening by phage display. | J Biomed Res | 2026 | https://conductscience.org/library/papers/41309056 | PubMed |
| 41,217,174 | Design of antibody structure-guided epitope vaccines in silico to induce potent immune responses against emerging viruses. | J Virol | 2025 | https://conductscience.org/library/papers/41217174 | PubMed |
| 41,117,360 | A unified topology-based classification of SARS-CoV-2 RBD neutralizing antibodies systematizes affinity trends across variants. | MAbs | 2025 | https://conductscience.org/library/papers/41117360 | PubMed |
| 41,085,626 | Utilizing Protein Bioinformatics to Delve Deeper into Immunopeptidomic Datasets with AIMS: An Automated Immune Molecule Separator. | Methods Mol Biol | 2026 | https://conductscience.org/library/papers/41085626 | PubMed |
| 41,077,783 | Rapid immunization and antibody redesign platform discovers broadly neutralizing antibodies against non-immunized SARS-CoV-2 variant. | Mol Ther | 2026 | https://conductscience.org/library/papers/41077783 | PubMed |
| 40,895,570 | From immune evasion to broad in silico binding: computational optimization of SARS-CoV-2 RBD-targeting nanobody. | Front Immunol | 2025 | https://conductscience.org/library/papers/40895570 | PubMed |
| 40,659,740 | An iterative strategy to design 4-1BB agonist nanobodies de novo with generative AI models. | Sci Rep | 2025 | https://conductscience.org/library/papers/40659740 | PubMed |
| 40,593,431 | B Cell Epitope Mapping by High-Density Competition ELISAs. | Methods Mol Biol | 2025 | https://conductscience.org/library/papers/40593431 | PubMed |
| 39,556,615 | Profiling serum immunodominance following SARS-CoV-2 primary and breakthrough infection reveals distinct variant-specific epitope usage and immune imprinting. | PLoS Pathog | 2024 | https://conductscience.org/library/papers/39556615 | PubMed |
| 39,463,836 | Engineering a SARS-CoV-2 Vaccine Targeting the Receptor-Binding Domain Cryptic-Face via Immunofocusing. | ACS Cent Sci | 2024 | https://conductscience.org/library/papers/39463836 | PubMed |
| 39,100,673 | A potent, broadly neutralizing human monoclonal antibody that efficiently protects hACE2-transgenic mice from infection with the Wuhan, BA.5, and XBB.1.5 SARS-CoV-2 variants. | Front Immunol | 2024 | https://conductscience.org/library/papers/39100673 | PubMed |
| 38,470,113 | Single-domain antibodies reveal unique borrelicidal epitopes on the Lyme disease vaccine antigen, outer surface protein A (OspA). | Infect Immun | 2024 | https://conductscience.org/library/papers/38470113 | PubMed |
| 38,456,672 | Experimental Structures of Antibody/MHC-I Complexes Reveal Details of Epitopes Overlooked by Computational Prediction. | J Immunol | 2024 | https://conductscience.org/library/papers/38456672 | PubMed |
Genes9
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ABL1 | 25 | PubTator's text mining | https://conductscience.org/library/genes/25 | NCBI Gene |
| ACE2 | 59,272 | PubTator's text mining | https://conductscience.org/library/genes/59272 | NCBI Gene |
| ALKBH1 | 8,846 | PubTator's text mining | https://conductscience.org/library/genes/8846 | NCBI Gene |
| ESS2 | 8,220 | PubTator's text mining | https://conductscience.org/library/genes/8220 | NCBI Gene |
| F5 | 2,153 | PubTator's text mining | https://conductscience.org/library/genes/2153 | NCBI Gene |
| IGH | 3,492 | PubTator's text mining | https://conductscience.org/library/genes/3492 | NCBI Gene |
| IGHJ6 | 28,475 | PubTator's text mining | https://conductscience.org/library/genes/28475 | NCBI Gene |
| IGHV3-53 | 28,420 | PubTator's text mining | https://conductscience.org/library/genes/28420 | NCBI Gene |
| IGHV3-66 | 28,412 | PubTator's text mining | https://conductscience.org/library/genes/28412 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37726484
GET https://conductscience.org/api/papers/v1/37726484/references?page=2